CADL Candel Therapeutics, Inc.
Healthcare$7.95-0.50%ClosedMarket Cap: $436.5M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$15.00
Target (Median)
$15.00
Target Range
$15.00 - $15.00
Upside from current price: 88.7%
Rating Distribution
0 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-18 | Citigroup | maintain | Buy | Buy |
| 2026-03-13 | Canaccord Genuity | maintain | Buy | Buy |
| 2025-12-08 | Stephens & Co. | maintain | Overweight | Overweight |
| 2025-11-21 | Freedom Broker | maintain | Buy | Buy |
| 2025-11-14 | Citigroup | maintain | Buy | Buy |
| 2025-09-29 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-03 | B of A Securities | downgrade | Neutral | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.67 | $42.0M | 3 |
| Sun Dec 31 | $0.51 | $159.9M | 6 |
| Mon Dec 31 | $2.47 | $398.3M | 4 |
| Tue Dec 31 | $5.33 | $759.8M | 2 |